| Application no. and date | 10776433.4 (espacenet) (Federated) (European Patent Register), 20101021 | | Patent/reg. no. and date | DK/EP 2496583, 20141210 | | Publication date | 20120912 | | Priority no. and date | US 257140 P, 20091102, US 372938 P, 20100812 | | EP pub. no. and date |
EP 2496583 20120912 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | P81406824DK00E | | Inventor | MASCITTI, Vincent, Pfizer Global Research and Development
Eastern Point Road
Groton, Connecticut 06340, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/357 (2006.01) , A61K 45/06 (2006.01) , C07D 493/08 (2006.01) | | Title | DIOXA-BICYCLO[3.2.1]OCTAN-2,3,4-TRIOL DERIVATER | | Int. application no. | IB2010054775 | | Int. publication no. | WO2011051864 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
